210 related articles for article (PubMed ID: 11684736)
1. Considerations in choosing an antidepressant.
Kingsbury SJ; Simpson GM
Psychiatr Serv; 2001 Nov; 52(11):1435-6. PubMed ID: 11684736
[No Abstract] [Full Text] [Related]
2. Choosing a first-line antidepressant: equal on average does not mean equal for everyone.
Simon G
JAMA; 2001 Dec; 286(23):3003-4. PubMed ID: 11743843
[No Abstract] [Full Text] [Related]
3. Depression: the relevance of the time factor.
Pinder RM
J Clin Psychiatry; 2001; 62 Suppl 15():5-7. PubMed ID: 11444764
[No Abstract] [Full Text] [Related]
4. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
Artigas F
Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
[No Abstract] [Full Text] [Related]
5. In the treatment of depression, does selectivity of action matter?
J Clin Psychiatry; 2004; 65 Suppl 4():60-2. PubMed ID: 15046543
[No Abstract] [Full Text] [Related]
6. Clinical implication of microdialysis findings.
Deakin JF; Graeff FG; Guimaraes FS
Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
[No Abstract] [Full Text] [Related]
7. Augmentation strategies with serotonergic-noradrenergic combinations.
Nelson JC
J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant selection in the postgenomic era.
Siever LJ
Biol Psychiatry; 2000 Nov; 48(9):875-7. PubMed ID: 11074224
[No Abstract] [Full Text] [Related]
9. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 18():23-9. PubMed ID: 9840195
[TBL] [Abstract][Full Text] [Related]
10. Depression in the medically ill: choosing an antidepressant.
Cunningham LA
J Clin Psychiatry; 1994 Sep; 55 Suppl A():90-7; discussion 98-100. PubMed ID: 7961548
[TBL] [Abstract][Full Text] [Related]
11. Biochemical effects of antidepressant augmentation.
Howland RH
Arch Gen Psychiatry; 1995 Feb; 52(2):156. PubMed ID: 7848052
[No Abstract] [Full Text] [Related]
12. Anxiolytic antidepressant augmentation.
Sussman N
J Clin Psychiatry; 1998; 59 Suppl 5():42-8; discussion 49-50. PubMed ID: 9635547
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors: placebo washouts inflate antidepressant effects in general practice.
van Marwijk HW; Adèr HJ
BMJ; 2005 Feb; 330(7488):420. PubMed ID: 15718553
[No Abstract] [Full Text] [Related]
14. Prescribing update: why choose duloxetine for depression?
Tobin ML
Issues Ment Health Nurs; 2007 Jan; 28(1):117-20. PubMed ID: 17130011
[No Abstract] [Full Text] [Related]
15. [Individualized treatment with antidepressants].
Köhler S; Arndt A; Sterzer P; Bschor T
Fortschr Neurol Psychiatr; 2013 Feb; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
[No Abstract] [Full Text] [Related]
16. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
[TBL] [Abstract][Full Text] [Related]
17. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in GRIK4 and the implications for antidepressant treatment.
Paddock S
Pharmacogenomics; 2008 Feb; 9(2):133-5. PubMed ID: 18370842
[No Abstract] [Full Text] [Related]
19. Suicide prevention and serotonergic drugs.
Montgomery SA
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
